Ultrasound Percapsular Nerve Group Block VS Fascia Iliaca Block for Hip Fracture
Hip Fracture, Analgesia, Acute Pain
About this trial
This is an interventional treatment trial for Hip Fracture focused on measuring hip fracture, nerve block, spinal anesthesia, analgesia
Eligibility Criteria
Inclusion Criteria:
- - Patients aged ≥ 65 years old and undergoing hip fracture surgical repair under continuous spinal anesthesia (CSA).
- Patients for whom pain was felt when raising the affected limb to 15 degrees (VERBAL PAIN SCALE =2)
Exclusion Criteria:
- - ASA physical status ≥ 4.
- Impaired cognition or Dementia.
- Multiple fractures.
- Contraindication to regional anesthesia.
- Patient's disapproval.
Sites / Locations
- Institut Kassab D'Orthopedie
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
fascial iliaca
Percapsular nerve group block
: A linear high frequency ultrasound probe (10-15MHz) was placed in a transverse direction over the anterior thigh below the inguinal ligament. We identified the femoral artery and the iliacus muscle lateral to it, covered by the fascia iliaca. The needle was inserted in plane and a 22 gauge, 50 mm needle was advanced until the tips placed underneath the fascia iliaca. Following negative aspiration, the local anesthetic solution was injected in 5mL increments while observing for adequate fluid spread in this plane for a total volume of 20 mL of 1.5% Lidocaine
A curvilinear low-frequency ultrasound probe (2-5MHz) was initially placed in a transverse plane over the anterior inferior iliac spine (AIIS) and then aligned with the pubic ramus by rotating the probe counterclockwise approximately 45 degrees. In this view, the iliopubic eminence (IPE), the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle were observed. A 22-gauge, 100-mm needle was inserted from lateral to medial in an in-plane approach to place the tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly. Following negative aspiration, the local anesthetic solution was injected in 5 mL increments while observing for adequate fluid spread in this plane for a total volume of 20 mL of 1.5% Lidocaine.